Main competitors
P/E (N) Price to Book (N) PEG (N) EV / Sales (N) EV / EBITDA (N) EV / EBIT (N) Dividend Yield (N) Capi.($)
-8.43x17.5x0.72x - -8.47x-8.04x - 6.6Cr
20.06x3.84x-2.15x6.16x13.43x15.6x1.6% 5.35TCr
32.54x6.01x0.8x8.23x25.52x26.09x0.06% 5.42TCr
-41.84x55.44x0.7x13.68x-39.9x-43.65x-.--% 2.37TCr
-17.97x1.1x2.79x4.21x-7.37x-6.05x-.--% 2.28TCr
24.64x2.4x1.9x4.81x12.68x15.2x-.--% 1.95TCr
25.1x2.83x-1.15x4.86x15.83x17.88x-.--% 1.78TCr
48x12.31x0.43x19.5x50.21x46.06x0.08% 1.6TCr
-526.19x21.59x10.68x37.05x-4130.99x-405.55x-.--% 1.54TCr
17.61x5x1.22x5.12x11.91x13.13x-.--% 1.41TCr
-75.06x27.23x1.67x7.83x-70.23x-56.26x-.--% 1.22TCr
-13.5x158.84x0.66x3519.63x-16.37x-13.36x-.--% 1.19TCr
-12.84x-87.14x6.32x95.2x-14.56x-14.17x-.--% 1.12TCr
3232.51x7.89x-31.67x13.85x84.54x290.01x-.--% 1.12TCr
-23.38x24.1x-0x21.49x-27.34x-22.11x-.--% 1.04TCr
-21.61x8.29x11x804.48x-18.87x-18.79x-.--% 983.28Cr
12.08x5.78x0.03x8.27x13.39x14.14x-.--% 908.13Cr
-17.73x8.81x3.79x113.69x-15.9x-14.45x - 882.22Cr
-9.16x - -0.07x - - - - 815.89Cr
-30.5x8.38x-0.55x - -28.09x-27.17x-.--% 824.23Cr
Average 130.72x 15.27x 0.36x 275.77x -218.45x -10.08x 0.1% 1.69TCr
Weighted average by Cap. 87.04x 13.44x 0.28x 169.92x -187.88x -6.11x 0.28%
Bio Therapeutic Drugs